SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marco Matejcic, M. Iqbal Parker, Gene–environment interactions in esophageal cancer, Critical Reviews in Clinical Laboratory Sciences, 2015, 52, 5, 211

    CrossRef

  2. 2
    Dojung Kim, Young-Joo Lee, Heui-Young Ryu, Jin-Hee Lee, Hyun-Kyung Kim, Eunhee Kim, Jae-Dong Moon, Dong Deuk Chang, Hae-Seong Yoon, Genetic polymorphisms in metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine, Journal of Applied Toxicology, 2013, 33, 1
  3. 3
    David W Hein, Mark A Doll, Accuracy of various humanNAT2SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes, Pharmacogenomics, 2012, 13, 1, 31

    CrossRef

  4. 4
    L. Taja-Chayeb, J.A. Agúndez, C. Miguez-Muñoz, A. Chavez-Blanco, A. Dueñas-Gonzalez, Arylamine N-acetyltransferase 2 genotypes in a Mexican population, Genetics and Molecular Research, 2012, 11, 2, 1082

    CrossRef

  5. 5
    Giuliano Di Pietro, Sandra Rocha Gadelha, Sandra Mara Bispo Sousa, Paulo Roberto Santana de Melo, Fabricio Rios Santos, N-acetyltransferase 2: Slow, intermediate or fast? A booming question of the molecular epidemiology in cancer research, Open Journal of Genetics, 2012, 02, 04, 221

    CrossRef

  6. 6
    Lucia Taja-Chayeb, Aurora González-Fierro, Cristian Miguez-Muñoz, Catalina Trejo-Becerril, Erick de la Cruz-Hernandez, David Cantu, Jose A. Agundez, Silvia Vidal-Millan, Olga Gutierrez, Alfonso Dueñas-González, Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype–genotype correlation with the sulfamethazine test, Pharmacogenetics and Genomics, 2011, 21, 12, 894

    CrossRef

  7. 7
    H. Wang, J. F. Yamamoto, C. Caberto, B. Saltzman, R. Decker, T. M. Vogt, L. Yokochi, S. Chanock, L. R. Wilkens, L. Le Marchand, Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia, Carcinogenesis, 2011, 32, 2, 203

    CrossRef

  8. 8
    Kristin J. Metry, Jason R. Neale, Mark A. Doll, Ashley L. Howarth, J. Christopher States, W. Glenn McGregor, William M. Pierce, David W. Hein, Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx), Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010, 684, 1-2, 66

    CrossRef

  9. 9
    Malika Khelil, Akila Zenati, Mohamed Makrelouf, Amel Otmane, Bouchentouf Tayebi, Polymorphisms in NAT2 Gene and Atherosclerosis in an Algerian Population, Archives of Medical Research, 2010, 41, 3, 215

    CrossRef

  10. 10
    Raquel L.F. Teixeira, Floriano P. Silva, Aline R. Silveira, Pedro H. Cabello, Leila Mendonça-Lima, Marcelo F. Rabahi, Afrânio L. Kritski, Fernanda C.Q. Mello, Philip N. Suffys, Antonio B. de Miranda, Adalberto R. Santos, Sequence analysis of NAT2 gene in Brazilians: Identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010, 683, 1-2, 43

    CrossRef

  11. 11
    T. S. Kang, S. K. Jin, J. E. Lee, S. W. Woo, J. Roh, Comparison of genetic polymorphisms of the NAT2 gene between Korean and four other ethnic groups, Journal of Clinical Pharmacy and Therapeutics, 2009, 34, 6
  12. 12
    David W Hein, N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 4, 353

    CrossRef

  13. 13
    F. A. Jefferson, G. H. Xiao, D. W. Hein, 4-Aminobiphenyl Downregulation of NAT2 Acetylator Genotype-Dependent N- and O-acetylation of Aromatic and Heterocyclic Amine Carcinogens in Primary Mammary Epithelial Cell Cultures from Rapid and Slow Acetylator Rats, Toxicological Sciences, 2008, 107, 1, 293

    CrossRef

  14. 14
    Chao Chen, Kate Z. Guyton, Do 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline data support the conclusion of threshold carcinogenic effects?, Stochastic Environmental Research and Risk Assessment, 2008, 22, 4, 487

    CrossRef

  15. 15
    Minjeong So, John B. Schenkman, James F. Rusling, Electrochemical biosensor featuring a two-enzyme pathway and DNA for screening toxic reactive metabolites of arylamines, Chemical Communications, 2008, 36, 4354

    CrossRef

  16. 16
    John C. Lipscomb, Torka S. Poet, In vitro measurements of metabolism for application in pharmacokinetic modeling, Pharmacology & Therapeutics, 2008, 118, 1, 82

    CrossRef

  17. 17
    Rolv T. Lie, Allen J. Wilcox, Jack Taylor, Håkon K. Gjessing, Ola Didrik Saugstad, Frank Aabyholm, Halvard Vindenes, Maternal Smoking and Oral Clefts, Epidemiology, 2008, 19, 4, 606

    CrossRef

  18. 18
    Kristin J. Metry, Shuang Zhao, Jason R. Neale, Mark A. Doll, J. Christopher States, W. Glenn McGregor, William M. Pierce, David W. Hein, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2, Molecular Carcinogenesis, 2007, 46, 7
  19. 19
    Edith Sim, Isaac Westwood, Elizabeth Fullam, ArylamineN-acetyltransferases, Expert Opinion on Drug Metabolism & Toxicology, 2007, 3, 2, 169

    CrossRef

  20. 20
    Jason A. Zell, Natalia A. Ignatenko, Hagit F. Yerushalmi, Argyrios Ziogas, David G. Besselsen, Eugene W. Gerner, Hoda Anton-Culver, Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival, International Journal of Cancer, 2007, 120, 3
  21. 21
    Tonika Bohnert, Lawrence L. Gan, In Vitro Experimental Models for Studying Drug Biotransformation, Handbook of Metabolic Pathways of Xenobiotics,